US 11890285
Combination therapies
granted A61KA61K2039/505A61K31/519
Quick answer
US patent 11890285 (Combination therapies) held by Mirati Therapeutics, Inc. expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Mirati Therapeutics, Inc.
- Grant date
- Tue Feb 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 43
- CPC classes
- A61K, A61K2039/505, A61K31/519, A61K39/39541, A61K39/39558